EU set to fine Teva for disparaging rival multiple sclerosis medicine, sources say, ET HealthWorld
London: EU antitrust regulators are set to fine world No. 1 generic drugmaker Teva in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone,…